← FDA Drug Approvals (Drugs@FDA)

CLARISCAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GE HEALTHCARE · Approved 2019-11-01

Drug application

FDA Application #

ANDA210016

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLARISCAN

Generic name

GADOTERATE MEGLUMINE

Active ingredients

GADOTERATE MEGLUMINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GE HEALTHCARE

Manufacturer

GE Healthcare

First approval

2019-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown